drugset / Trial / NCT07543276
Pharmacokinetic (PK) Evaluation of Nalmefene Formulations
RandomizedCrossoverOpen-labelTreatment
Summary
This study is designed to characterize the PK of nalmefene following IV bolus and IM injections using nalmefene 0.5 mg (0.94% MgCl2) and IV bolus of 0.5 mg nalmefene hydrochloride injection in healthy subjects.
Timeline
- Start
- 2026-02-06
- Primary completion
- 2026-04-03
- Completion
- 2026-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nalmefene | Small molecule | 0.5 mg | Intravenous |